Localized delivery of Cl-amidine from electrospun polydioxanone templates to regulate acute neutrophil NETosis

A preliminary evaluation of the PAD4 inhibitor for tissue engineering

Allison E. Fetz, Indira Neeli, Karyl K. Buddington, Robert W. Read, Matthew P. Smeltzer, Marko Radic, Gary L. Bowlin

Research output: Contribution to journalArticle

Abstract

Upon interaction, neutrophils can potentially release neutrophil extracellular traps (NETs) on the surface of an implanted electrospun template, which may be a significant preconditioning event for implantable biomaterials of yet unknown consequences. In this study, we investigated the potential of polydioxanone templates as a delivery vehicle for Cl-amidine, an inhibitor of peptidyl arginase deiminase 4 (PAD4), and if drug elution could attenuate PAD4-mediated NETosis in the vicinity of implanted templates. Electrospun polydioxanone templates were fabricated with distinct architectures, small diameter (0.4 μm) or large diameter (1.8 μm) fibers, and incorporated with 0-5 mg/mL Cl-amidine to examine dose-dependent effects. Acute neutrophil-template interactions were evaluated in vitro with freshly isolated human neutrophils and in vivo with a rat subcutaneous implant model. The in vitro results suggest large diameter templates with 0 mg/mL Cl-amidine significantly attenuate NETosis compared to small diameter templates. As the drug concentration increased, NETosis was significantly decreased on small diameter templates in a dose-dependent manner. The opposite was observed for large diameter templates, indicating multiple mechanisms of NETosis may be regulating neutrophil template preconditioning. Similar results were observed in vivo, verifying local NETosis inhibition by Cl-amidine eluting templates in a physiological environment. Importantly, large diameter templates with Cl-amidine enhanced neutrophil invasion and survival, supporting the potential for long-term modulation of tissue integration and regeneration. This preliminary study demonstrates a novel delivery vehicle for Cl-amidine that can be used to regulate acute NETosis as the potential critical link between the innate immune response, inflammation, and template-guided tissue regeneration.

Original languageEnglish (US)
Article number289
JournalFrontiers in Pharmacology
Volume9
Issue numberMAR
DOIs
StatePublished - Mar 28 2018

Fingerprint

Polydioxanone
Arginase
Tissue Engineering
Neutrophils
Guided Tissue Regeneration
Biocompatible Materials
Innate Immunity
Pharmaceutical Preparations
N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide
Regeneration
Inflammation
Survival

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Localized delivery of Cl-amidine from electrospun polydioxanone templates to regulate acute neutrophil NETosis : A preliminary evaluation of the PAD4 inhibitor for tissue engineering. / Fetz, Allison E.; Neeli, Indira; Buddington, Karyl K.; Read, Robert W.; Smeltzer, Matthew P.; Radic, Marko; Bowlin, Gary L.

In: Frontiers in Pharmacology, Vol. 9, No. MAR, 289, 28.03.2018.

Research output: Contribution to journalArticle

Fetz, Allison E. ; Neeli, Indira ; Buddington, Karyl K. ; Read, Robert W. ; Smeltzer, Matthew P. ; Radic, Marko ; Bowlin, Gary L. / Localized delivery of Cl-amidine from electrospun polydioxanone templates to regulate acute neutrophil NETosis : A preliminary evaluation of the PAD4 inhibitor for tissue engineering. In: Frontiers in Pharmacology. 2018 ; Vol. 9, No. MAR.
@article{99d8b88490f74fe08162cadf65c9049f,
title = "Localized delivery of Cl-amidine from electrospun polydioxanone templates to regulate acute neutrophil NETosis: A preliminary evaluation of the PAD4 inhibitor for tissue engineering",
abstract = "Upon interaction, neutrophils can potentially release neutrophil extracellular traps (NETs) on the surface of an implanted electrospun template, which may be a significant preconditioning event for implantable biomaterials of yet unknown consequences. In this study, we investigated the potential of polydioxanone templates as a delivery vehicle for Cl-amidine, an inhibitor of peptidyl arginase deiminase 4 (PAD4), and if drug elution could attenuate PAD4-mediated NETosis in the vicinity of implanted templates. Electrospun polydioxanone templates were fabricated with distinct architectures, small diameter (0.4 μm) or large diameter (1.8 μm) fibers, and incorporated with 0-5 mg/mL Cl-amidine to examine dose-dependent effects. Acute neutrophil-template interactions were evaluated in vitro with freshly isolated human neutrophils and in vivo with a rat subcutaneous implant model. The in vitro results suggest large diameter templates with 0 mg/mL Cl-amidine significantly attenuate NETosis compared to small diameter templates. As the drug concentration increased, NETosis was significantly decreased on small diameter templates in a dose-dependent manner. The opposite was observed for large diameter templates, indicating multiple mechanisms of NETosis may be regulating neutrophil template preconditioning. Similar results were observed in vivo, verifying local NETosis inhibition by Cl-amidine eluting templates in a physiological environment. Importantly, large diameter templates with Cl-amidine enhanced neutrophil invasion and survival, supporting the potential for long-term modulation of tissue integration and regeneration. This preliminary study demonstrates a novel delivery vehicle for Cl-amidine that can be used to regulate acute NETosis as the potential critical link between the innate immune response, inflammation, and template-guided tissue regeneration.",
author = "Fetz, {Allison E.} and Indira Neeli and Buddington, {Karyl K.} and Read, {Robert W.} and Smeltzer, {Matthew P.} and Marko Radic and Bowlin, {Gary L.}",
year = "2018",
month = "3",
day = "28",
doi = "10.3389/fphar.2018.00289",
language = "English (US)",
volume = "9",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media S. A.",
number = "MAR",

}

TY - JOUR

T1 - Localized delivery of Cl-amidine from electrospun polydioxanone templates to regulate acute neutrophil NETosis

T2 - A preliminary evaluation of the PAD4 inhibitor for tissue engineering

AU - Fetz, Allison E.

AU - Neeli, Indira

AU - Buddington, Karyl K.

AU - Read, Robert W.

AU - Smeltzer, Matthew P.

AU - Radic, Marko

AU - Bowlin, Gary L.

PY - 2018/3/28

Y1 - 2018/3/28

N2 - Upon interaction, neutrophils can potentially release neutrophil extracellular traps (NETs) on the surface of an implanted electrospun template, which may be a significant preconditioning event for implantable biomaterials of yet unknown consequences. In this study, we investigated the potential of polydioxanone templates as a delivery vehicle for Cl-amidine, an inhibitor of peptidyl arginase deiminase 4 (PAD4), and if drug elution could attenuate PAD4-mediated NETosis in the vicinity of implanted templates. Electrospun polydioxanone templates were fabricated with distinct architectures, small diameter (0.4 μm) or large diameter (1.8 μm) fibers, and incorporated with 0-5 mg/mL Cl-amidine to examine dose-dependent effects. Acute neutrophil-template interactions were evaluated in vitro with freshly isolated human neutrophils and in vivo with a rat subcutaneous implant model. The in vitro results suggest large diameter templates with 0 mg/mL Cl-amidine significantly attenuate NETosis compared to small diameter templates. As the drug concentration increased, NETosis was significantly decreased on small diameter templates in a dose-dependent manner. The opposite was observed for large diameter templates, indicating multiple mechanisms of NETosis may be regulating neutrophil template preconditioning. Similar results were observed in vivo, verifying local NETosis inhibition by Cl-amidine eluting templates in a physiological environment. Importantly, large diameter templates with Cl-amidine enhanced neutrophil invasion and survival, supporting the potential for long-term modulation of tissue integration and regeneration. This preliminary study demonstrates a novel delivery vehicle for Cl-amidine that can be used to regulate acute NETosis as the potential critical link between the innate immune response, inflammation, and template-guided tissue regeneration.

AB - Upon interaction, neutrophils can potentially release neutrophil extracellular traps (NETs) on the surface of an implanted electrospun template, which may be a significant preconditioning event for implantable biomaterials of yet unknown consequences. In this study, we investigated the potential of polydioxanone templates as a delivery vehicle for Cl-amidine, an inhibitor of peptidyl arginase deiminase 4 (PAD4), and if drug elution could attenuate PAD4-mediated NETosis in the vicinity of implanted templates. Electrospun polydioxanone templates were fabricated with distinct architectures, small diameter (0.4 μm) or large diameter (1.8 μm) fibers, and incorporated with 0-5 mg/mL Cl-amidine to examine dose-dependent effects. Acute neutrophil-template interactions were evaluated in vitro with freshly isolated human neutrophils and in vivo with a rat subcutaneous implant model. The in vitro results suggest large diameter templates with 0 mg/mL Cl-amidine significantly attenuate NETosis compared to small diameter templates. As the drug concentration increased, NETosis was significantly decreased on small diameter templates in a dose-dependent manner. The opposite was observed for large diameter templates, indicating multiple mechanisms of NETosis may be regulating neutrophil template preconditioning. Similar results were observed in vivo, verifying local NETosis inhibition by Cl-amidine eluting templates in a physiological environment. Importantly, large diameter templates with Cl-amidine enhanced neutrophil invasion and survival, supporting the potential for long-term modulation of tissue integration and regeneration. This preliminary study demonstrates a novel delivery vehicle for Cl-amidine that can be used to regulate acute NETosis as the potential critical link between the innate immune response, inflammation, and template-guided tissue regeneration.

UR - http://www.scopus.com/inward/record.url?scp=85044658238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044658238&partnerID=8YFLogxK

U2 - 10.3389/fphar.2018.00289

DO - 10.3389/fphar.2018.00289

M3 - Article

VL - 9

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

IS - MAR

M1 - 289

ER -